Loading provider…
Loading provider…
Hematology & Oncology Physician in Duarte, CA
NPI: 1205271640Primary Employer
City of Hope Medical - San Bernardino Radiation Oncology
cityofhope.org
HQ Phone
Get D.O. Gregory's Phone Numberphone_androidMobile
Get D.O. Gregory's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State License
2014 - 2025

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
University of California (San Francisco)/Fresno
Residency • Internal Medicine
2013 - 2016
WesternU College of Osteopathic Medicine of the Pacific
westernu.edu
Medical School
Until 2013
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 190 | 463 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 189 | 280 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 68 | 68 |
| 4 | 99497Advance care planning by the physician or other qualified health care professional | 21 | 25 |
| 5 | 99204New patient office or other outpatient visit, 45-59 minutes | 16 | 16 |
Targeting CNS Metastases in Non-Small Cell Lung Cancer With Evolving Approaches Using Molecular Markers: A Review.
Authors: Rimas Lukas, Mike Chen, Bihong Chen, Jyoti Malhotra, Arya Amini, Ravi Salgia
Goblet cell carcinoid of the appendix - diagnostic challenges and treatment updates: a case report and review of the literature.
Authors: Subramanyeswara Arekapudi, Shreyas Saligram
Publication Date: 2018-02-02
Goblet cell carcinoid of the appendix – diagnostic challenges and treatment updates: a case report and review of the literature
Authors: Kristin Jensen, Subramanyeswara Arekapudi
Lead Sponsor: Karyopharm Therapeutics Inc
Collaborators: Belgian Gynaecological Oncology Group, GOG Foundation, Israeli Society of Gynecologic Oncology, Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies, Spanish Research Group in Ovarian Cancer, The Central and Eastern European Gynecologic Oncology Group, North-Eastern German Society of Gynaecologic Oncology
Intervention / Treatment: DRUG: Selinexor, DRUG: Matching placebo for selinexor
Lead Sponsor: Napo Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Crofelemer 125 MG [Mytesi]
Lead Sponsor: OnQuality Pharmaceuticals (USA) LLC
Intervention / Treatment: DRUG: Vehicle Ointment, DRUG: OQL011